UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Luxturna to open gene therapies market: analyst
by Nam Doo-hyun
2018-01-10 15:48
Test for fetal sex chromosome defects wins patent
by Nam Doo-hyun
2018-01-10 14:39
Antibodies drug suggested against N. Korean anthrax threat
by Nam Doo-hyun
2018-01-05 12:03
Venture capital investment in biomedical sector drops 20% in 2017
by Nam Doo-hyun
2018-01-04 09:30
70% of biotech firms enjoy stock price gains in 2017
by Nam Doo-hyun
2018-01-02 17:42
라인
Kolon Life Science’s shares plummet on drifting export deal
by Nam Doo-hyun
2017-12-21 13:16
₩500-billion Invossa technology export to Japan in peril
by Nam Doo-hyun
2017-12-20 14:59
Will Takeda, Dong-A ST benefit from new hypertension guideline?
by Nam Doo-hyun
2017-12-19 16:15
Boehringer Ingelheim Korea’s labor union protests early retirement program
by Nam Doo-hyun
2017-12-19 14:35
‘Celltrion’s annual revenue to top ₩3 trillion in 5 years’
by Nam Doo-hyun
2017-12-18 15:55
라인
Yuhan’s chemo combo YH24931 more effective than immunotherapy alone
by Nam Doo-hyun
2017-12-18 11:51
‘Postmenopausal women in 50s shouldn’t take phytoestrogen’
by Nam Doo-hyun
2017-12-18 10:49
‘Surge of gene-therapy providing hospitals to benefit Invossa’
by Nam Doo-hyun
2017-12-12 15:59
PCL shares rise despite regulator’s warning
by Nam Doo-hyun
2017-12-12 11:02
Oscotec shares rebound on launch of US clinical trial
by Nam Doo-hyun
2017-12-11 15:50
라인
ToolGen’s shares jump on gene therapy market expectations
by Nam Doo-hyun
2017-12-11 15:16
Government’s mobile healthcare pilot project proves effective
by Nam Doo-hyun
2017-12-07 14:37
Novartis Korea faces tax investigation
by Nam Doo-hyun
2017-12-06 10:55
Kolon Life Science confident to make Invossa global blockbuster
by Nam Doo-hyun
2017-12-06 09:30
Shares of biotech firms, listed with ‘exceptional techs,’ rise above offer price
by Nam Doo-hyun
2017-12-05 14:38
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top